Ambiful 250 mg/5 ml
Ambiful 250 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 67512. The authorisation holder is Curatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 February 2020 and the authorisation is valid without a time limit. ATC code L02BA03 places the medicine in the group Endocrine therapy.
| Authorisation number | 67512 |
|---|---|
| Name | Ambiful 250 mg/5 ml |
| Full name | Ambiful 250 mg/5 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Curatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BA03 |
| First authorisation | 10 February 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ambiful 250 mg/5 ml, Injektionslösung in einer Fertigspritze | B | 10 February 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 2 | Fertigspritze(n) | L02BA03 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ambiful 250 mg/5 ml authorised in Switzerland?
Yes. Ambiful 250 mg/5 ml is authorised by Swissmedic under authorisation number 67512, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ambiful 250 mg/5 ml have?
Ambiful 250 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ambiful 250 mg/5 ml?
The authorisation holder is Curatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.